William Blair Dumps $21 Million of Healthcare Platform Doximity Stock

William Blair sold 372,184 shares of Doximity; estimated trade size was $20.89 million (quarterly average pricing). Quarter-end Doximity position value fell by $184.77 million, reflecting both trading and price changes.

The Motley Fool • Feb 9, 2026

Why Doximity Stock Plummeted Today

Doximity's sales growth slowed to 10% in Q3, and its net income dipped. Worse yet, the company guided for sales growth of only 4% in the upcoming quarter.

The Motley Fool • Feb 6, 2026

Doximity Stock Falls Despite Q3 Earnings & Revenues Beat Estimates

DOCS beats Q3 EPS and revenue estimates, but shares plunge 38.5% after hours as margins contract and FY26 revenue guidance is lowered.

Zacks Investment Research • Feb 6, 2026

Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript

Doximity, Inc. (DOCS) Q3 2026 Earnings Call Transcript

Seeking Alpha • Feb 6, 2026

Doximity Announces Fiscal 2026 Third Quarter Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025. “We're proud to deliver another quarter of strong profits and record engagement,” said Jeff Tangney, co-founder and CEO of Doximity. “Our newsfeed had more than 1 million quarterly active prescribers, our workflow products had 720,000 (a record QoQ jump), and our nascent AI products had over 30.

Business Wire • Feb 5, 2026

Doximity Stock Is Collapsing After Hours: Here's Why

Doximity, which operates an online networking service for medical professionals, reported third-quarter revenue of $185.05 million, beating estimates of $182.20 million, according to Benzinga Pro. Revenue was up 10% on a year-over-year basis.

Benzinga • Feb 5, 2026

Doximity (DOCS) Q3 Earnings and Revenues Surpass Estimates

Doximity (DOCS) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.45 per share a year ago.

Zacks Investment Research • Feb 5, 2026

Here's What Key Metrics Tell Us About Doximity (DOCS) Q3 Earnings

While the top- and bottom-line numbers for Doximity (DOCS) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks Investment Research • Feb 6, 2026

Doximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive Year

SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named the #1 Telehealth Video Conferencing Platform in the 2026 Best in KLAS Report. This is the fifth consecutive year that Doximity has earned the top spot, underscoring its position as a trusted, long-term partner for physicians and health systems. In addition to securing the #1 spot, Doximity received A-level ratings in all c.

Business Wire • Feb 5, 2026

Doximity (DOCS) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates

Evaluate the expected performance of Doximity (DOCS) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Investment Research • Feb 2, 2026